Drugmakers Rip HHS At DC Circ. For Price-Disclosure Rule
Major drugmakers are urging the D.C. Circuit to uphold the invalidation of a new regulation mandating the disclosure of drug prices in television advertisements, saying the U.S. Department of Health and...To view the full article, register now.
Already a subscriber? Click here to view full article